Cargando…
Bayes analysis supports null hypothesis of anti‐amyloid beta therapy in Alzheimer's disease
Numerous clinical trials of anti‐amyloid beta (Aβ) immunotherapy in Alzheimer's disease have been performed. None of these have provided convincing evidence for beneficial effects. Using traditional frequentist meta‐analysis, the conclusion is that there is absence of evidence for a therapeutic...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251763/ https://www.ncbi.nlm.nih.gov/pubmed/34057297 http://dx.doi.org/10.1002/alz.12379 |